Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism — CAPE-AMI  

Acute Myocardial Infarction Clinical Trial

Official title: Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in Acute Myocardial Infarction (AMI) Patients With Abnormal Glucose Metabolism: a Multicenter Prospective Randomized Clinical Trial

Status Recruiting

Clinical Trial Summary

Different types of statins show different influences on glycometabolism. There are no systemic analyses of the effects that statins exert on the metabolism of glucoses so far in China. This research aims to compare impacts on the glycometabolism of pitavastatin in AMI patients with atorvastatin and to accumulate data for guiding the utilization of statins.

Clinical Trial Description

General study design:

This study is a prospective, multicenter, open and randomized controlled clinical trial, which utilize online registration database of CAMI to do the enrollment, randomization and follow-up. We will select 14 of the centers to compete into the group. The researchers used a central randomized distribution system to prescribe medication for patients. Follow the method of drug administration approved by the state drug administration department, we will estimate the efficacy and safety of treatment at the following timing: baseline, one month and six months after treatment. ;

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Glucose Metabolism Disorders
• Infarction
• Metabolic Diseases
• Myocardial Infarction

• NCT number: NCT04945122
• Study type: Interventional
• Source: Chinese Academy of Medical Sciences, Fuwai Hospital
• Contact: Xiao-jin Gao, M.D.
• Phone: +8613810644383
• Email: sophie_gao@sina.com
• Status: Recruiting
• Phase: Phase 4
• Start date: October 1, 2015
• Completion date: December 31, 2023